UY32382A - Procedimiento para la preparación de la n-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-n-metil-acetamida - Google Patents

Procedimiento para la preparación de la n-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-n-metil-acetamida

Info

Publication number
UY32382A
UY32382A UY0001032382A UY32382A UY32382A UY 32382 A UY32382 A UY 32382A UY 0001032382 A UY0001032382 A UY 0001032382A UY 32382 A UY32382 A UY 32382A UY 32382 A UY32382 A UY 32382A
Authority
UY
Uruguay
Prior art keywords
acetamide
methyl
fluoro
phenyl
preparation
Prior art date
Application number
UY0001032382A
Other languages
English (en)
Inventor
Joan Sallares
Marquillas Francisco
Original Assignee
Interquim Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interquim Sa filed Critical Interquim Sa
Publication of UY32382A publication Critical patent/UY32382A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se refiere a un procedimiento de preparación del compuesto N-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-N-metil-acetamida (I), intermedio en la síntesis de compuestos con afinidad sobre el receptor GABa. La N-(5-acetil-2-fluorofenil)-n-metil-acetamida (VI) se hace reaccionar con un exceso de N,N-dimetilformamida dimetilacetal (NNDMF-DMA). La presente invención proporciona también un nuevo procedimiento para la preparación del producto con afinidad GABAa N-{2-fluoro-5-[3-(tiofeno)-2-carbonil-pirazolo[1,5-a]pirimidin-7-il]fenil}-N-metilacetamida (II), que comprende a) metilación de N-(5-acetil-2-fluorofenil)-N-acetamida (IV) con un sulfato de metilo, b) reacción del compuesto (VI) resultante con NNDMF-DMA, y c) reacción del compuesto (I) resultante con (5-amino-1H-pirazol-4-il)tiofeno-2-il-metanona (III) en ácido acético glacial. La presente invención se refiere también al nuevo intermedio (VI).
UY0001032382A 2009-01-13 2010-01-13 Procedimiento para la preparación de la n-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-n-metil-acetamida UY32382A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200900089 2009-01-13

Publications (1)

Publication Number Publication Date
UY32382A true UY32382A (es) 2010-07-30

Family

ID=42199324

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032382A UY32382A (es) 2009-01-13 2010-01-13 Procedimiento para la preparación de la n-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-n-metil-acetamida

Country Status (22)

Country Link
US (1) US8163903B2 (es)
EP (1) EP2387557B1 (es)
JP (1) JP5507579B2 (es)
KR (1) KR101680396B1 (es)
CN (2) CN102282123A (es)
AR (1) AR075009A1 (es)
AU (1) AU2010205739B2 (es)
BR (1) BRPI1006150A2 (es)
CA (1) CA2747392C (es)
CY (1) CY1114407T1 (es)
DK (1) DK2387557T3 (es)
ES (1) ES2427972T3 (es)
HK (1) HK1214585A1 (es)
MX (1) MX2011007323A (es)
PE (1) PE20120111A1 (es)
PL (1) PL2387557T3 (es)
PT (1) PT2387557E (es)
RU (1) RU2503655C2 (es)
SI (1) SI2387557T1 (es)
TW (1) TWI389912B (es)
UY (1) UY32382A (es)
WO (1) WO2010081788A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557597B (zh) * 2013-12-11 2017-08-04 浙江龙盛集团股份有限公司 一种3‑(n,n‑二取代)氨基乙酰苯胺类化合物的清洁生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20050070555A1 (en) 2001-12-21 2005-03-31 Bayer Healthcare Ag Aroyl pyridinones
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP1736475A1 (en) 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
US20080045547A1 (en) * 2006-07-07 2008-02-21 Lippa Arnold S Salts And Co-Crystals of Pyrazolopyrimidine Compounds, Compositions Thereof And Methods For Their Production And Use

Also Published As

Publication number Publication date
KR101680396B1 (ko) 2016-11-28
CN104945272A (zh) 2015-09-30
JP2012515149A (ja) 2012-07-05
US20110275809A1 (en) 2011-11-10
BRPI1006150A2 (pt) 2018-01-16
KR20110108346A (ko) 2011-10-05
TWI389912B (zh) 2013-03-21
AR075009A1 (es) 2011-03-02
RU2011133958A (ru) 2013-02-20
WO2010081788A1 (en) 2010-07-22
JP5507579B2 (ja) 2014-05-28
SI2387557T1 (sl) 2013-12-31
RU2503655C2 (ru) 2014-01-10
EP2387557B1 (en) 2013-06-19
CN102282123A (zh) 2011-12-14
PL2387557T3 (pl) 2013-12-31
CA2747392A1 (en) 2010-07-22
TW201026704A (en) 2010-07-16
ES2427972T3 (es) 2013-11-05
PT2387557E (pt) 2013-09-11
CY1114407T1 (el) 2016-08-31
US8163903B2 (en) 2012-04-24
CA2747392C (en) 2016-10-18
AU2010205739A1 (en) 2011-07-21
EP2387557A1 (en) 2011-11-23
HK1214585A1 (zh) 2016-07-29
AU2010205739B2 (en) 2015-12-10
PE20120111A1 (es) 2012-02-10
MX2011007323A (es) 2011-07-29
DK2387557T3 (da) 2013-09-08

Similar Documents

Publication Publication Date Title
CO6311106A2 (es) Derivados novedosos del acido oleanólico con saturacion del anillo c
AR075291A1 (es) Proceso para la preparcion de derivados de l-alanina protegidos
IN2010DN02582A (es)
CY1119452T1 (el) Μια μεθοδος παρασκευης 2-αιθοξυ-1-(2'-((υδροξυamino) ιμινομεθυλο) διφαινυλ-4-υλο) μεθυλο)-1η- βενζο (d) ιμιδαζολο-7-καρβοξυλικο οξυ και τους εστερες αυτου
SV2010003739A (es) Nuevos derivados de acido l-glutamico y l-glutamina marcados con [f-18] (i), su uso y procedimiento para su preparacion
AR074863A1 (es) Proceso y compuestos intermedios para preparar un inhibidor de proteasa macrociclico del vhc
MX2010009860A (es) Sintesis total de salinosporamida a y sus analogos.
MY150973A (en) Method for producing diamine derivative
ES2555139T3 (es) Nuevo procedimiento para la preparación de Linezolid y sus nuevos intermedios
HRP20200488T1 (hr) Proizvodnja 4,5,6,7-tetrahidroizozaksolo[5,4-c]piridin-3-ola
UY32382A (es) Procedimiento para la preparación de la n-[5-(3-dimetilamino-acriloil)-2-fluoro-fenil]-n-metil-acetamida
EA200700767A1 (ru) Способ получения пиразолов
MX2010009926A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico.
ME00927B (me) Novi postupak za sintezu agomelatina
WO2012111027A3 (en) Process for pemetrexed disodium
NZ597550A (en) Process for the preparation of o-desmethyl venlafaxine and intermediate for use therein
MX2012000431A (es) Procedimientos para 3-amino-5-oxo-4,5-dihidro-[1,2,4]triazinas sustituidas.
BR112013011244A2 (pt) processo para a preparação de derivados e ácido 3-(6-amino-piridin-3il)-2-acrílico
RU2013110311A (ru) Синтез соединений тиазолидиндиона
ES2615729T3 (es) Proceso para preparar 3-haloalquilpirazoles
ECSP088933A (es) Métodos para preparar derivados de ácido glutámico y sus intermedios
MX367426B (es) Procedimiento para la preparacion de oxidoles y anilinas orto-sustituidas y su uso como productos intermedios para sintesis.
WO2015022702A3 (en) Process for preparation of 4,5-dimethoxybenzene derivatives and use in the synthesis of ivabradine and salts thereof
ES2317359T3 (es) Procedimiento para la preparacion de 4-hidroxialquilamino-2-nitro-anisoles.
IL214511A (en) METHOD FOR PRODUCING A CYCLEOPROPENCARBOXYLIC ACID ESTER

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20201221